85 related articles for article (PubMed ID: 16416866)
1. [Gene therapy for leukemia].
Kaneko S; Onodera M; Nagasawa T
Nihon Rinsho; 2005 Dec; 63 Suppl 12():637-40. PubMed ID: 16416866
[No Abstract] [Full Text] [Related]
2. [Gene therapy for glioma].
Mizuno M; Yoshida J
Nihon Rinsho; 2005 Dec; 63 Suppl 12():562-5. PubMed ID: 16416853
[No Abstract] [Full Text] [Related]
3. [Prostate cancer gene therapy].
Nasu Y; Abarzua F; Kumon H
Nihon Rinsho; 2005 Dec; 63 Suppl 12():544-7. PubMed ID: 16416850
[No Abstract] [Full Text] [Related]
4. [Gene therapy for ovarian cancer].
Hamada K
Nihon Rinsho; 2005 Dec; 63 Suppl 12():552-61. PubMed ID: 16416852
[No Abstract] [Full Text] [Related]
5. [Gene therapy for malignant brain tumors--the present conditions and the prospects].
Nakahara N; Yoshida J
Nihon Rinsho; 2005 Sep; 63 Suppl 9():499-503. PubMed ID: 16201571
[No Abstract] [Full Text] [Related]
6. [In vitro model for the suicide gene therapy of AFP-producing gastric cancer using HSVtk gene under control of AFP promoter].
Nakaya H
Hokkaido Igaku Zasshi; 2003 May; 78(3):203-9. PubMed ID: 12795172
[No Abstract] [Full Text] [Related]
7. Cells producing recombinant retrovirus with thymidine kinase gene from Herpes simplex virus suitable for human cancer gene therapy.
Hlavatý J; Hlubinová K; Bies J; Altaner C
Neoplasma; 1999; 46(6):329-34. PubMed ID: 10732860
[TBL] [Abstract][Full Text] [Related]
8. [Gene therapy for myeloid leukemia].
Heike Y
Nihon Rinsho; 2009 Oct; 67(10):1958-63. PubMed ID: 19860197
[TBL] [Abstract][Full Text] [Related]
9. [Gene therapy for hematological malignancies].
Tani K
Rinsho Byori; 1998 Aug; 46(8):797-803. PubMed ID: 9760832
[No Abstract] [Full Text] [Related]
10. [Gene and cell therapy for relapsed leukemia after allo-stem cell transplantation].
Onodera M
Nihon Rinsho; 2007 Jan; 65 Suppl 1():637-41. PubMed ID: 17476761
[No Abstract] [Full Text] [Related]
11. Gene therapy for ovarian cancer (review).
Wolf JK; Jenkins AD
Int J Oncol; 2002 Sep; 21(3):461-8. PubMed ID: 12168087
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus-mediated tissue-targeted expression of the HSVtk gene for the treatment of breast cancer.
Anderson LM; Swaminathan S; Zackon I; Tajuddin AK; Thimmapaya B; Weitzman SA
Gene Ther; 1999 May; 6(5):854-64. PubMed ID: 10505111
[TBL] [Abstract][Full Text] [Related]
13. An improved retroviral vector encoding the herpes simplex virus thymidine kinase gene increases antitumor efficacy in vivo.
Lyons RM; Forry-Schaudies S; Otto E; Wey C; Patil-Koota V; Kaloss M; McGarrity GJ; Chiang YL
Cancer Gene Ther; 1995 Dec; 2(4):273-80. PubMed ID: 8548581
[TBL] [Abstract][Full Text] [Related]
14. Gene therapy: recent progress in the clinical oncology arena.
Pandha HS; Martin LA; Rigg AS; Ross P; Dalgleish AG
Curr Opin Mol Ther; 2000 Aug; 2(4):362-75. PubMed ID: 11249766
[TBL] [Abstract][Full Text] [Related]
15. Potential use of CD40 ligand for immunotherapy of childhood B-cell precursor acute lymphoblastic leukaemia.
D'Amico G; Marin V; Biondi A; Bonamino MH
Best Pract Res Clin Haematol; 2004 Sep; 17(3):465-77. PubMed ID: 15498717
[TBL] [Abstract][Full Text] [Related]
16. Suicide genes and bystander killing: local and distant effects.
Dilber MS; Smith CI
Gene Ther; 1997 Apr; 4(4):273-4. PubMed ID: 9176510
[No Abstract] [Full Text] [Related]
17. Immune response induced by retrovirus-mediated HSV-tk/GCV pharmacogene therapy in patients with glioblastoma multiforme.
Rainov NG; Kramm CM; Banning U; Riemann D; Holzhausen HJ; Heidecke V; Burger KJ; Burkert W; Körholz D
Gene Ther; 2000 Nov; 7(21):1853-8. PubMed ID: 11110418
[TBL] [Abstract][Full Text] [Related]
18. Technology evaluation: gene therapy (mesothelioma), NCI.
Banerjee D
Curr Opin Mol Ther; 1999 Aug; 1(4):517-20. PubMed ID: 11713768
[TBL] [Abstract][Full Text] [Related]
19. [Gene therapy for hepatocellular carcinoma. From the idea to clinical trials].
Gerolami R; Uch R; Cardoso J; Bagnis C; Mannoni P; Bréchot C
Gastroenterol Clin Biol; 2001 Mar; 25(3):273-86. PubMed ID: 11395675
[No Abstract] [Full Text] [Related]
20. Co-expression of the herpes simplex virus thymidine kinase gene potentiates methotrexate resistance conferred by transfer of a mutated dihydrofolate reductase gene.
Mineishi S; Nakahara S; Takebe N; Banerjee D; Zhao SC; Bertino JR
Gene Ther; 1997 Jun; 4(6):570-6. PubMed ID: 9231073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
